Cardlytics (NASDAQ:CDLX) Cut to Sell at Wall Street Zen

Wall Street Zen cut shares of Cardlytics (NASDAQ:CDLXFree Report) from a hold rating to a sell rating in a report published on Saturday.

A number of other equities analysts also recently commented on the stock. Evercore ISI cut their target price on shares of Cardlytics from $3.00 to $2.00 and set an “in-line” rating on the stock in a research note on Friday, August 8th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Cardlytics in a report on Thursday, October 30th. Three equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $2.25.

View Our Latest Research Report on Cardlytics

Cardlytics Stock Performance

NASDAQ CDLX opened at $1.43 on Friday. The company has a debt-to-equity ratio of 2.87, a current ratio of 1.14 and a quick ratio of 1.14. Cardlytics has a 1-year low of $0.85 and a 1-year high of $4.81. The firm has a market capitalization of $77.31 million, a P/E ratio of -0.68 and a beta of 1.47. The business’s 50-day simple moving average is $1.86 and its 200-day simple moving average is $1.77.

Cardlytics (NASDAQ:CDLXGet Free Report) last posted its quarterly earnings results on Wednesday, November 5th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.08. The firm had revenue of $52.03 million for the quarter, compared to analyst estimates of $56.64 million. Cardlytics had a negative net margin of 44.12% and a negative return on equity of 235.70%. Cardlytics has set its Q4 2025 guidance at EPS. Equities analysts predict that Cardlytics will post -1.52 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Amit Gupta sold 68,685 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $1.12, for a total transaction of $76,927.20. Following the completion of the sale, the chief executive officer directly owned 491,759 shares in the company, valued at $550,770.08. This trade represents a 12.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last three months, insiders have sold 159,335 shares of company stock valued at $204,204. Corporate insiders own 4.40% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of CDLX. Lane Generational LLC acquired a new stake in Cardlytics during the 1st quarter valued at approximately $1,109,000. Brooktree Capital Management grew its position in shares of Cardlytics by 27.6% during the first quarter. Brooktree Capital Management now owns 223,625 shares of the company’s stock worth $407,000 after buying an additional 48,415 shares in the last quarter. LPL Financial LLC increased its stake in shares of Cardlytics by 30.3% in the first quarter. LPL Financial LLC now owns 859,406 shares of the company’s stock worth $1,564,000 after buying an additional 200,087 shares during the last quarter. Deutsche Bank AG increased its stake in shares of Cardlytics by 123.8% in the first quarter. Deutsche Bank AG now owns 48,728 shares of the company’s stock worth $89,000 after buying an additional 26,958 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in Cardlytics by 34.2% in the first quarter. Invesco Ltd. now owns 97,054 shares of the company’s stock valued at $177,000 after acquiring an additional 24,731 shares in the last quarter. Institutional investors and hedge funds own 68.10% of the company’s stock.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Articles

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.